Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Berhanu, Alemayehu"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Berhanu Alemayehu, Lara J. Wolfson, X. Lu, M. Heisen, S Carrol, J F Clark-Wright, S. Klijn, D A R Mathijssen, B C P van Dijk
Publikováno v:
Expert Review of Vaccines. 19:1167-1175
Objectives: Non-reconstituted, hexavalent vaccines (HV-NRs) can facilitate clinical practice by shortening vaccine preparation and administration time and by reducing the risk of vaccination errors compared to combination vaccines requiring reconstit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30ac39967f6f2243605dd69572e484a3
https://doi.org/10.1080/14760584.2020.1873770
https://doi.org/10.1080/14760584.2020.1873770
Autor:
Liknaw Bewket Zeleke, Getachew Mullu Kassa, Addisu Alehegn Alemu, Amanuel Alemu Abajobir, Yohannes Mazeingia Teka, Berhanu Alemayehu
Publikováno v:
Open Access Journal of Contraception. 11:43-52
Background Women's decision-making power influences the use of family planning. It is one of the denied fundamental rights of women, particularly in developing countries. Objective This study was aimed to assess married women's decision-making power
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::777bf67c123b9d14be64c07dab43f0cb
https://doi.org/10.2147/oajc.s250462
https://doi.org/10.2147/oajc.s250462
Supplemental material, sj-docx-1-smo-10.1177_20503121221127880 for Stunting and associated factors among school-age children (5–14 years) in Mulo district, Oromia region, Ethiopia by Alemayehu Berhanu, Sileshi Garoma, Godana Arero and Getu Mosisa i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::57309e07830e44e2d662ca6e46c9ac1c
Publikováno v:
SAGE Open Medicine; 10/3/2022, Vol. 10, p1-10, 10p
Publikováno v:
Journal of Diabetes and its Complications. 31:1620-1623
The objective of this study was to evaluate diabetes-related healthcare resource use and associated costs in patients with type 2 diabetes (T2DM) treated with a sulfonylurea (SU), with and without hypoglycemia.In this retrospective cohort study, pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5601beceb0b70b9ddb7aded88a6ad6a1
https://doi.org/10.1016/j.jdiacomp.2017.07.012
https://doi.org/10.1016/j.jdiacomp.2017.07.012
Publikováno v:
The American journal of managed care. 24(8 Spec)
The objective of this literature review was to evaluate the costs associated with the use of long-acting insulin analogues (LAIAs) compared with non-LAIA agents, including human insulin, oral antidiabetic drugs, and other injectable therapies, in the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f461a9622c41a9e228d9a9b0643bac56
https://pubmed.ncbi.nlm.nih.gov/30020738
https://pubmed.ncbi.nlm.nih.gov/30020738
Publikováno v:
Diabetes. 67
This study sought to develop and implement a usability/preference survey to compare the pen devices used with innovator insulin glargine and MK-1293 (Pen X). Type 1 and type 2 diabetes patients and certified diabetes educators (CDEs) in the U.S., Can
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7980e8dcc39e613f561929a9a2a7f0f9
https://doi.org/10.2337/db18-966-p
https://doi.org/10.2337/db18-966-p
Autor:
Chitra Karki, Berhanu Alemayehu, Allison M. Nguyen, Michael Crutchlow, Marco DiBonaventura, Bijal Shah-Manek
Publikováno v:
Diabetes. 67
This study examines the predictors of preferences of pen devices used with originator insulin glargine and MK-1293, a recently approved biosimilar insulin glargine (referred to as “Pen X”), among patients with diabetes. Adult patients with type 1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f7b7f825ed81fad0a7bfe62af8c2dbbd
https://doi.org/10.2337/db18-2272-pub
https://doi.org/10.2337/db18-2272-pub
Autor:
Ya-Ting Chen, Zhiwen Liu, Berhanu Alemayehu, Gary S. Marshall, Lara J. Wolfson, Michelle G. Goveia, David R. Johnson
Publikováno v:
Open Forum Infectious Diseases
Background The recommended US infant immunization schedule includes doses of DTaP, IPV, Hib and HepB during the first 6 months of life. The majority of infants receive DTaP as one of the two pentavalent combination vaccines (DTaP-IPV/Hib or DTaP-HepB
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::185c77a2d619ed51ad95314ff92b45f2
http://europepmc.org/articles/PMC6810147
http://europepmc.org/articles/PMC6810147